Clinical Trials Browser

Phase 1/2 × Interventional × viscum album peptide × Clear all

NCT02007005 2015-05-06

Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer

Phase 1/2 Completed

Non-Muscle Invasive Bladder Neoplasms